ESSA PHARMA INC

Historical 13F Holders

Symbol
EPIX
CUSIP
29668H708
All holders as of
Q3 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 29668H708 since 12/18/2024, largest first.

Filer % of Class Filed
Soleus Capital Master Fund, L.P. 13D/A
9.8% 7/21/2025
Event 7/17/2025
BML Investment Partners, L.P. 13D 9.5% 4/24/2025
Event 4/24/2025
Soleus Capital, LLC 13G/A
5.1% 2/11/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Morgan Stanley 13G/A
4.0% 10/7/2025
Event 9/30/2025
RTW Investments, LP 13G/A
2.5% 2/14/2025
Event 12/31/2024
Biotechnology Value Fund L P 13D/A
0% 10/14/2025
Event 10/9/2025
PFM Health Sciences, LP 13G/A
0% 2/14/2025
Event 12/31/2024
Tang Capital Management LLC 13G/A
0% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 34 22.5 M $4.30M
2025 Q2 38 31.0 M $52.7M
2025 Q1 37 31.7 M $50.1M
2024 Q4 47 32.9 M $58.8M
2024 Q3 34 35.1 M $213M
2024 Q2 33 35.2 M $185M
2024 Q1 35 35.0 M $297M
2023 Q4 33 34.8 M $229M
2023 Q3 37 33.5 M $103M
2023 Q2 40 33.2 M $89.8M
2023 Q1 40 33.1 M $98.3M
2022 Q4 48 33.4 M $84.1M
2022 Q3 56 33.8 M $62.2M
2022 Q2 61 37.8 M $119M
2022 Q1 72 37.2 M $230M
2021 Q4 61 37.3 M $530M
2021 Q3 76 37.2 M $297M
2021 Q2 81 34.2 M $976M
2021 Q1 71 30.8 M $896M
2020 Q4 41 23.1 M $274M
2020 Q3 36 20.3 M $139M
2020 Q2 21 14.1 M $86.5M
2020 Q1 18 14.2 M $56.6M
2019 Q4 22 13.9 M $76.1M
2019 Q3 17 12.3 M $41.0M
2019 Q2 9 5.48 M $13.1M
2019 Q1 9 3.83 M $13.1M
2018 Q4 9 3.83 M $8.04M
2018 Q3 9 3.83 M $11.5M
2018 Q2 8 2.75 M $10.4M